valine and thromboplastin

valine has been researched along with thromboplastin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertina, RM; Cupers, R; Mannucci, PM; Poort, SR; Reinalda-Poot, HH; Reitsma, PH; van der Linden, IK1
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Gulba, D; Haller, H; Luft, FC; Luther, T; Mackman, N; Mervaala, EM; Müller, DN; Park, JK; Schmidt, F; Schneider, W; Theuer, J1
Bernardi, F; Camire, RM; High, KA; Marchetti, G; Pinotti, M; Pollak, ES; Tidd, T; Toso, R1
Beck, DO; Bukys, MA; Kalafatis, M; Singh, LS1
Osório e Castro, VR; Vernon, LP1
Nielsen, PF; Olsen, OH; Persson, E1
Chen, LF; Ke, YN; Li, N; Zhu, WL1
Chang, KC; Ha, YM; Kang, YJ; Kim, HJ; Park, EJ; Park, SW1

Other Studies

8 other study(ies) available for valine and thromboplastin

ArticleYear
Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
    The Journal of biological chemistry, 1990, Jul-05, Volume: 265, Issue:19

    Topics: Amino Acid Sequence; Antibodies, Monoclonal; Arginine; Binding Sites; Binding, Competitive; Chymotrypsin; DNA Restriction Enzymes; Factor IX; Factor VIIa; Factor X; Factor XIa; Hemophilia A; Humans; Molecular Sequence Data; Molecular Weight; Mutation; Protein Conformation; Prothrombin Time; Thromboplastin; Valine

1990
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    The American journal of pathology, 2000, Volume: 157, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Coagulation Factors; Blood Pressure; Cell Line; CHO Cells; Coronary Disease; Coronary Vessels; Cricetinae; Extracellular Matrix Proteins; Heart Ventricles; Humans; Inflammation; Integrin alpha4beta1; Integrins; NF-kappa B; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Lymphocyte Homing; RNA, Messenger; Tetrazoles; Thromboplastin; Transcription Factor AP-1; Valine; Valsartan; Vascular Resistance

2000
Factor VII mutant V154G models a zymogen-like form of factor VIIa.
    The Biochemical journal, 2003, Feb-01, Volume: 369, Issue:Pt 3

    Topics: Alanine; Amino Acid Chloromethyl Ketones; Binding Sites; Enzyme Precursors; Factor VII; Factor VIIa; Humans; Isoleucine; Point Mutation; Protein Conformation; Serine Proteinase Inhibitors; Thromboplastin; Valine

2003
Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.
    The Journal of biological chemistry, 2003, Jul-25, Volume: 278, Issue:30

    Topics: Amino Acids; Animals; Anisotropy; Binding Sites; Blotting, Western; COS Cells; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Factor Va; Factor Xa; Glutamic Acid; Humans; Kinetics; Mutagenesis, Site-Directed; Mutation; Peptides; Protein Binding; Prothrombin; Recombinant Proteins; Spectrometry, Fluorescence; Thrombin; Thromboplastin; Time Factors; Transfection; Tyrosine; Valine

2003
Stimulation of prothrombinase activity by the nonapeptide Thr-Trp-Ala-Arg-Asn-Ser-Tyr-Asn-Val, a segment of a plant thionin.
    Peptides, 2003, Volume: 24, Issue:4

    Topics: Calcium; Cell Membrane; Cysteine; Cystine; Dose-Response Relationship, Drug; Erythrocyte Membrane; Factor Va; Factor Xa; Humans; Nuts; Peptides; Plant Proteins; Pyrularia; Spectrophotometry; Temperature; Thrombin; Thromboplastin; Time Factors; Valine

2003
Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
    Biochemistry, 2004, Nov-09, Volume: 43, Issue:44

    Topics: Allosteric Site; Amino Acid Sequence; Animals; Cell Line; Chromogenic Compounds; Cricetinae; Cysteine; Enzyme Activation; Enzyme Precursors; Factor VIIa; Genetic Variation; Humans; Hydrolysis; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Structure, Secondary; Substrate Specificity; Thermodynamics; Thromboplastin; Transfection; Valine

2004
[Effects of valsartan and captopril on expressions and activities of tissue factor and tissue factor pathway inhibitor].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:10

    Topics: Animals; Captopril; Cells, Cultured; Endothelium, Vascular; Male; Proton-Translocating ATPases; Rabbits; RNA, Messenger; Tetrazoles; Thromboplastin; Valine; Valsartan

2006
Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:10

    Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucose Tolerance Test; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Tetrazoles; Thromboplastin; Toll-Like Receptor 2; Toll-Like Receptor 4; Valine; Valsartan

2014